brimindinvest.com / compare / ametek-vs-roperLIVE
AME
AMETEK, Inc. · Industrials - Electronic Instruments & Electromechanical
$237.42
+7.29% this month
VERSUS
COMPARE
ROP
Roper Technologies, Inc. · Industrials / Technology - Specialty Software & Industrial
$330.26
+0.41% this month
Scoreboard verdict
Across AI score, momentum, valuation, upside, operating margin
AME
2
ROP
3
ROP LEADS 3/5
Comparison scoreboard
ROP LEADS 3/5
AI Score
AME 52.3
ROP 40.0
1Y Return
AME +35.24%
ROP -41.30%
Fwd P/E
AME 25.78
ROP 14.06
Target Up.
AME +14.11%
ROP +33.38%
Op. Margin
AME 26.30%
ROP 27.18%
Metrics last refreshed: 6/20/2026
Quick take

AME vs ROP Stock Comparison: AI Score, Valuation, Performance and Upside

AME (AMETEK) and ROP (Roper Technologies) are two elite industrial technology compounders with exceptional capital allocation track records — AMETEK as the niche electronic instruments and electromechanical devices leader, and Roper as a hybrid industrial-software company increasingly weighted toward high-retention vertical software acquisitions.

AME vs ROP pits two premium capital allocation compounders against each other — AMETEK's precision instruments acquisition machine versus Roper's strategic pivot toward niche vertical software businesses.

Live analysis · updated 6/20/2026

ROP holds the edge across 3 of 5 key metrics in this comparison. AME has delivered stronger 1-year price return (+35.24% vs -41.30%), though ROP trades at the lower forward P/E (14.06x vs 25.78x). ROP leads on both revenue growth (11.30%) and operating margin (27.18%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for ROP (+33.38%) than for AME (+14.11%).

Normalized 1Y performance
AME
ROP
Recent returns
AME
ROP
Analyst price targets & sentiment
AME
Price target range
analyst mean$259.16
current price$237.42
+14.1% upside to analyst mean
ROP · 16 analysts
STRONG BUYHOLDSTRONG SELL
Buy (1.9/5.0)
Price target range
analyst high$732.00
analyst mean$446.80
current price$330.26
+33.4% upside to analyst mean
Who should consider this stock?
AME may suit investors who:
  • Want a proven industrial technology compounder with exceptional acquisition integration and niche instrumentation dominance
  • Value AMETEK's aerospace, defense, and medical instrument exposure with strong aftermarket service recurring revenue
  • Prefer a more traditional industrial technology business model over Roper's hybrid software transition story
ROP may suit investors who:
  • Want an industrial compounder increasingly weighted toward high-retention vertical software businesses with recurring revenue
  • Value Roper's exceptional free cash flow conversion providing capital for high-ROIC niche software acquisitions
  • See the software business model transition as increasing earnings quality, predictability, and growth sustainability
Performance & AI score
MetricAMEROP
AI score52.340.0
AI rank#334#1108
Latest close$237.42$330.26
1M return+7.29%+0.41%
6M return+18.77%-26.97%
1Y return+35.24%-41.30%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

PeriodAMEROP
1Y ago$13.36K (+33.6%)
started 2025-06-18
$5.94K (-40.6%)
started 2025-06-18
5Y ago$18.66K (+86.6%)
started 2021-06-21
$7.54K (-24.6%)
started 2021-06-21
10Y ago$57.11K (+471.1%)
started 2016-06-20
$21.56K (+115.6%)
started 2016-06-20

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
MetricAMEROP
Market cap$52.06B$33.8B
Trailing P/E34.3620.92
Forward P/E25.7814.06
Price/SalesN/A8.51
EV/Revenue7.115.41
Analyst target$259.16$446.80
Target upside+14.11%+33.38%
Growth, profitability & risk
MetricAMEROP
Revenue growth11.30%11.30%
Earnings growth14.50%59.20%
EPS growth+14.50%+59.20%
FCF margin+18.23%+26.74%
Operating margin26.30%27.18%
Profit margin20.11%21.12%
ROIC proxy14.63%9.01%
Return on equity14.63%9.01%
Dividend yield0.60%1.09%
Beta1.000.76
Debt/equity22.4955.61
Current ratio1.140.53
Quick ratio0.610.42
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
AME max drawdown13.70%
ROP max drawdown44.93%
AME max wkly drop7.21%
ROP max wkly drop12.31%
5Y risk snapshot
AME max drawdown27.06%
ROP max drawdown46.79%
AME max wkly drop11.91%
ROP max wkly drop12.31%
10Y risk snapshot
AME max drawdown42.72%
ROP max drawdown46.79%
AME max wkly drop24.02%
ROP max wkly drop17.24%
Performance metrics by period
PeriodMetricAMEROP
1YGrowth+33.56%-40.57%
CAGR+33.62%-40.62%
Sharpe ratio1.22-2.13
Max drawdown13.70%44.93%
Max daily drop3.89%9.64%
Max wkly drop7.21%12.31%
5YGrowth+81.96%-26.28%
CAGR+12.74%-5.92%
Sharpe ratio0.46-0.39
Max drawdown27.06%46.79%
Max daily drop8.27%9.64%
Max wkly drop11.91%12.31%
10YGrowth+437.45%+104.23%
CAGR+18.32%+7.41%
Sharpe ratio0.630.23
Max drawdown42.72%46.79%
Max daily drop16.17%10.19%
Max wkly drop24.02%17.24%
Business comparison
CategoryAMEROP
CompanyAMETEK, Inc.Roper Technologies, Inc.
SectorIndustrialsTechnology
IndustryN/ASoftware - Application
Core businessAMETEK is a leading manufacturer of electronic instruments and electromechanical devices for aerospace, defense, medical, industrial, and power markets, generating durable margins through precision instruments and specialty materials with significant aftermarket service revenue.Roper Technologies is a diversified industrial technology company operating vertically-focused software businesses (healthcare IT, legal, engineering software) alongside industrial systems businesses, with an explicit strategy of acquiring niche, high-retention software businesses.
Investor focusInvestors track AMETEK's organic revenue growth, EBITDA margins in the 23-25%+ range, consistent acquisition integration track record, and EPS growth compound rate as a quality industrial compounder.Investors track Roper's organic revenue and ARR growth across its software businesses, free cash flow conversion above 100% of net income, and M&A pipeline as it deploys capital into high-ROIC niche software acquisitions.
AME strengths
  • Exceptional acquisition and integration discipline — AMETEK has compounded earnings through disciplined bolt-on acquisitions for decades
  • Highly differentiated niche instruments for aerospace, defense, and medical applications have strong competitive moats from precision and regulatory qualification
  • Aftermarket parts and service revenue provides recurring, high-margin revenue alongside new equipment sales
ROP strengths
  • Vertically-focused software acquisitions (healthcare credentialing, legal billing, engineering workflow) have near-100% retention and minimal competition given deep customer integration
  • Exceptional free cash flow conversion — software businesses require minimal capital reinvestment, generating cash for further acquisitions
  • Roper's software transition has shifted the business toward higher-quality recurring revenue from mission-critical vertical applications
Risks to watch — AME
  • Defense and aerospace cycles can create lumpiness in revenue growth despite the portfolio's diversification
  • Acquisition multiples in the specialty industrial space have increased significantly, potentially reducing future deal returns
  • Integration of larger acquisitions requires careful management to maintain AMETEK's historically strong operating margins
Risks to watch — ROP
  • Industrial segment revenue is cyclical with capital expenditure in the markets it serves
  • Roper's software valuations may be challenged if software multiples compress in valuation-sensitive rate environments
  • Integration discipline across diverse software businesses requires careful management of multiple niche verticals simultaneously
Frequently asked questions
AMETEK is called a compounder because it consistently compounds earnings at above-market rates through a combination of organic growth, operating margin expansion, and acquisition of niche businesses in attractive specialty niches — creating a self-reinforcing cycle where cash generation funds more acquisitions that generate more cash.
AI Prediction SignalNext 5 trading days
Members only
AME
+2.8%BUY
ROP
+1.1%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

Related comparisons
More comparisons
Browse all 1,000 comparisons →